CardiaBeat Now NDICardiaBeat Now NDI

 MIGDAL HAEMEQ, Israel—Enzymotec announced the U.S. Food and Drug Administration (FDA) approved the company’s petition for New Dietary Ingredient (NDI) status for its CardiaBeat™ dietary ingredient. The product is designed to deliver plant sterols plus long-chain omega-3 essential fatty acids (EFAs), including docosahexaenoic acid (DHA) and eicosapenaenoic acid (EPA), to improve various cardiovascular disease risk factors. Enzymotec (www.enzymotec.com) develops and manufactures bio-functional ingredients for dietary supplements, functional foods and infant formulas.